Literature DB >> 26402087

Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline.

Octavio Rodríguez-Gómez1, Carla Abdelnour1, Frank Jessen2, Sergi Valero3, Merçé Boada1.   

Abstract

Subjective cognitive decline (SCD) has been proposed as a marker of neurodegeneration in cognitively normal elderly. This idea is supported by the growing evidence that SCD is associated with Alzheimer's disease (AD) biomarkers and increases the risk of future cognitive impairment. Nevertheless, this evidence is not complete, since other studies have not found these associations. This discrepancy could have a methodological basis. It is well known that across the broad spectrum of degenerative disease from healthy controls to dementia, the research setting affects key characteristics of the sample such as age, educational level, or family history of dementia. However, virtually no studies have specifically tested the influence of sampling and recruitment methods in SCD research. Population-based samples are less biased and therefore they probably are more suitable for the study of memory complaints as a symptom at the population level. On the other hand, the memory clinic setting could introduce a set of biases that make these patients more likely to develop cognitive impairment. Thus, memory clinic would be the most cost-effective context in which to study the phenomenology of SCD due to AD and eventually recruit patients for secondary prevention trials. However, this general hypothesis needs to be tested. Studies that compare samples of patients with SCD from different settings are necessary. Sometimes it is difficult for patients with subtle forms of cognitive impairment to access specialized diagnostic centers. Based in our experience we state that Open House type initiatives may be useful for attracting these individuals to memory clinics.

Entities:  

Keywords:  Alzheimer’s disease; epidemiologic research design; epidemiologic studies; patient selection; risk; sampling; selection bias; subjective cognitive decline

Mesh:

Year:  2015        PMID: 26402087     DOI: 10.3233/JAD-150189

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  15 in total

1.  Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.

Authors:  Rosalinde E R Slot; Sietske A M Sikkes; Johannes Berkhof; Henry Brodaty; Rachel Buckley; Enrica Cavedo; Efthimios Dardiotis; Francoise Guillo-Benarous; Harald Hampel; Nicole A Kochan; Simone Lista; Tobias Luck; Paul Maruff; José Luis Molinuevo; Johannes Kornhuber; Barry Reisberg; Steffi G Riedel-Heller; Shannon L Risacher; Susanne Roehr; Perminder S Sachdev; Nikolaos Scarmeas; Philip Scheltens; Melanie B Shulman; Andrew J Saykin; Sander C J Verfaillie; Pieter Jelle Visser; Stephanie J B Vos; Michael Wagner; Steffen Wolfsgruber; Frank Jessen; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

2.  Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting.

Authors:  Beth E Snitz; Tianxiu Wang; Yona Keich Cloonan; Erin Jacobsen; Chung-Chou H Chang; Tiffany F Hughes; M Ilyas Kamboh; Mary Ganguli
Journal:  Alzheimers Dement       Date:  2018-01-18       Impact factor: 21.566

Review 3.  The characterisation of subjective cognitive decline.

Authors:  Frank Jessen; Rebecca E Amariglio; Rachel F Buckley; Wiesje M van der Flier; Ying Han; José Luis Molinuevo; Laura Rabin; Dorene M Rentz; Octavio Rodriguez-Gomez; Andrew J Saykin; Sietske A M Sikkes; Colette M Smart; Steffen Wolfsgruber; Michael Wagner
Journal:  Lancet Neurol       Date:  2020-01-17       Impact factor: 44.182

4.  The Impact of Study Setting on Clinical Characteristics in Older Chinese Adults with Subjective Cognitive Decline: Baseline Investigation of Convenience and Population-Based Samples.

Authors:  Mingyan Zhao; Guanqun Chen; Taoran Li; Can Sheng; Yuxia Li; Ying Han
Journal:  Biomed Res Int       Date:  2021-06-04       Impact factor: 3.411

5.  Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.

Authors:  Bjørn-Eivind Kirsebom; Ragna Espenes; Knut Waterloo; Erik Hessen; Stein Harald Johnsen; Geir Bråthen; Dag Aarsland; Tormod Fladby
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 6.  Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.

Authors:  Mercè Boada; Miguel A Santos-Santos; Octavio Rodríguez-Gómez; Montserrat Alegret; Pilar Cañabate; Asunción Lafuente; Carla Abdelnour; Mar Buendía; Maria José de Dios; América Morera; Ángela Sanabria; Laura Campo; Agustín Ruiz; Lluís Tárraga
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).

Authors:  Itziar de Rojas; J Romero; O Rodríguez-Gomez; P Pesini; A Sanabria; A Pérez-Cordon; C Abdelnour; I Hernández; M Rosende-Roca; A Mauleón; L Vargas; M Alegret; A Espinosa; G Ortega; S Gil; M Guitart; A Gailhajanet; M A Santos-Santos; Sonia Moreno-Grau; O Sotolongo-Grau; S Ruiz; L Montrreal; E Martín; E Pelejà; F Lomeña; F Campos; A Vivas; M Gómez-Chiari; M A Tejero; J Giménez; V Pérez-Grijalba; G M Marquié; G Monté-Rubio; S Valero; A Orellana; L Tárraga; M Sarasa; A Ruiz; M Boada
Journal:  Alzheimers Res Ther       Date:  2018-11-29       Impact factor: 6.982

8.  Visual impairment in aging and cognitive decline: experience in a Memory Clinic.

Authors:  Marta Marquié; Miguel Castilla-Martí; Sergi Valero; Joan Martínez; Domingo Sánchez; Isabel Hernández; Maitée Rosende-Roca; Liliana Vargas; Ana Mauleón; Octavio Rodríguez-Gómez; Carla Abdelnour; Silvia Gil; Miguel A Santos-Santos; Montserrat Alegret; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Natalia Roberto; Sonia Moreno-Grau; Itziar de Rojas; Rafael Simó; Andreea Ciudin; Cristina Hernández; Adelina Orellana; Gemma Monté-Rubio; Alba Benaque; Agustín Ruiz; Lluís Tárraga; Mercè Boada
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.379

9.  Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.

Authors:  Elizabeth Kuhn; Inès Moulinet; Audrey Perrotin; Renaud La Joie; Brigitte Landeau; Clémence Tomadesso; Alexandre Bejanin; Siya Sherif; Vincent De La Sayette; Béatrice Desgranges; Denis Vivien; Géraldine Poisnel; Gaëlle Chételat
Journal:  Alzheimers Res Ther       Date:  2019-07-08       Impact factor: 6.982

10.  Subjective Cognitive Decline.

Authors:  Andrea Tales; Frank Jessen; Christopher Butler; Gordon Wilcock; Judith Phillips; Tony Bayer
Journal:  J Alzheimers Dis       Date:  2015-09-24       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.